Label

How We Work

Grant

Back

Print

Yale University


October 2008
to develop an antigen delivery machine based on the type III protein delivery system that will not require the use of live-attenuated bacteria, offering a safer vaccine platform.
$100,000
18
Discovery and Translational Sciences
Global Health
New Haven, Connecticut
http://www.yale.edu

Visit Our Blog